Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adva Levy

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
JAMA Oncology|May 28, 2021
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for CancerAmir Massarweh, Noa Eliakim-Raz, Amos Stemmer, et al.
Molecular Oncology|December 7, 2021
Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysisVikrant Palande, Tali Siegal, Rajesh Detroja, et al.
Cancer Medicine|December 29, 2023
Is serum-derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory studyOrit Uziel, Andrew A Kanner, Einat Beery, et al.
Molecular Cell|March 3, 2018
The Ubiquitin E3/E4 Ligase UBE4A Adjusts Protein Ubiquitylation and Accumulation at Sites of DNA Damage, Facilitating Double-Strand Break RepairKeren Baranes-Bachar, Adva Levy-Barda, Judith Oehler, et al.
Journal of Crohn'S & Colitis|July 29, 2024
Discordant Effects of Janus Kinase Inhibition Ex Vivo on Inflammatory Responses in Colonic Compared to Ileal MucosaKawsar Kaboub, Hanan Abu-Taha, Jessica Arrouasse, et al.
Oncotarget|April 21, 2017
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancerNoa Rabinowicz, Lingegowda S Mangala, Kevin R Brown, et al.
Vaccines|July 29, 2023
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel DiseasesHadar Edelman-Klapper, Keren Masha Rabinowitz, Eran Zittan, et al.
Cancer Immunology Research|May 16, 2024
PVRIG is Expressed on Stem-Like T Cells in Dendritic Cell-Rich Niches in Tumors and Its Blockade May Induce Immune Infiltration in Non-Inflamed TumorsZoya Alteber, Gady Cojocaru, Roy Z Granit, et al.
NAR Cancer|November 3, 2025
Brain tumor classification from FFPE samples using nanopore methylation sequencingGalina Feinberg-Gorenshtein, Assaf Grunwald, Carlo Vermeulen, et al.
Frontiers in Immunology|March 15, 2024
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapyJair Bar, Raya Leibowitz, Niels Reinmuth, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
JAMA Oncology|May 28, 2021
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for CancerAmir Massarweh, Noa Eliakim-Raz, Amos Stemmer, et al.
Molecular Oncology|December 7, 2021
Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysisVikrant Palande, Tali Siegal, Rajesh Detroja, et al.
Cancer Medicine|December 29, 2023
Is serum-derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory studyOrit Uziel, Andrew A Kanner, Einat Beery, et al.
Molecular Cell|March 3, 2018
The Ubiquitin E3/E4 Ligase UBE4A Adjusts Protein Ubiquitylation and Accumulation at Sites of DNA Damage, Facilitating Double-Strand Break RepairKeren Baranes-Bachar, Adva Levy-Barda, Judith Oehler, et al.
Journal of Crohn'S & Colitis|July 29, 2024
Discordant Effects of Janus Kinase Inhibition Ex Vivo on Inflammatory Responses in Colonic Compared to Ileal MucosaKawsar Kaboub, Hanan Abu-Taha, Jessica Arrouasse, et al.
Oncotarget|April 21, 2017
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancerNoa Rabinowicz, Lingegowda S Mangala, Kevin R Brown, et al.
Vaccines|July 29, 2023
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel DiseasesHadar Edelman-Klapper, Keren Masha Rabinowitz, Eran Zittan, et al.
Cancer Immunology Research|May 16, 2024
PVRIG is Expressed on Stem-Like T Cells in Dendritic Cell-Rich Niches in Tumors and Its Blockade May Induce Immune Infiltration in Non-Inflamed TumorsZoya Alteber, Gady Cojocaru, Roy Z Granit, et al.
NAR Cancer|November 3, 2025
Brain tumor classification from FFPE samples using nanopore methylation sequencingGalina Feinberg-Gorenshtein, Assaf Grunwald, Carlo Vermeulen, et al.
Frontiers in Immunology|March 15, 2024
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapyJair Bar, Raya Leibowitz, Niels Reinmuth, et al.
Pageof 3